PHASE III STUDY OF CCNU, CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE, AND VP-16 IN SMALL-CELL CARCINOMA OF THE LUNGETTINGER DS; LAGAKOS S.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 8; PP. 1544-1554; BIBL. 19 REF.Article

A CASE STUDY OF STATISTICS IN THE REGULATORY PROCESS: THE FD & C RED NO. 40 EXPERIMENTSLAGAKOS S; MOSTELLER F.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 1; PP. 197-212; BIBL. 31 REF.Article

The loss in efficiency from misspecifying covariates in proportional hazards regression modelsLAGAKOS, S. W.Biometrika. 1988, Vol 75, Num 1, pp 156-160, issn 0006-3444Article

Loss in efficiency caused by omitting covariates and misspecifiying exposure in logistic regression modelsBEGG, M. D; LAGAKOS, S.Journal of the American Statistical Association. 1993, Vol 88, Num 421, pp 166-170, issn 0162-1459Article

Epidemic models, empirical studies, and uncertaintyDE GRUTTOLA, V; LAGAKOS, S.Lecture notes in biomathematics. 1989, Vol 83, pp 38-57, issn 0341-633X, 20 p.Article

Estimation of a failure time distribution based on imperfect diagnostic testsBALASUBRAMANIAN, R; LAGAKOS, S. W.Biometrika. 2003, Vol 90, Num 1, pp 171-182, issn 0006-3444, 12 p.Article

Bias correction for score tests arising from misspecified proportional hazards regression modelsDIRIENZO, G; LAGAKOS, S. W.Biometrika. 2001, Vol 88, Num 2, pp 421-434, issn 0006-3444Article

Estimation of the infection time and latency distribution of AIDS with doubly censored dataGOMEZ, G; LAGAKOS, S. W.Biometrics. 1994, Vol 50, Num 1, pp 204-212, issn 0006-341XArticle

Effects of mismodeling on tests of association based on logistic regression modelsBEGG, M; LAGAKOS, S.Annals of statistics. 1992, Vol 20, Num 4, pp 1929-1952, issn 0090-5364Article

RADIOTHERAPY OF REGIONAL EPIDERMOID CARCINOMA OF THE LUNG: A STUDY IN FRACTIONATIONSEALY R; LAGAKOS S; BARKLEY T et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 7; PP. 1338-1345; BIBL. 25 REF.Article

ADRIAMYCIN IN THE TREATMENT OF FAR-ADVANCED LUNG CANCER.KNIGHT EW; LAGAKOS S; STOLBACH L et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 7; PP. 939-941; BIBL. 6 REF.Article

Regression analysis of tumour prevalence dataDINSE, G. E; LAGAKOS, S. W.Applied statistics. 1983, Vol 32, Num 3, pp 236-248, issn 0035-9254Article

MECHLORETHAMINE (NSC-762) PLUS CCNU (NSC-79037) IN THE TREATMENT OF INOPERABLE SQUAMOUS AND LARGE CELL CARCINOMA OF THE LUNGEDMONSON JH; LAGAKOS S; STOLBACH L et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 625-627; BIBL. 4 REF.Article

ADRIAMYCIN: COMPARISON OF A 5-WEEK SCHEDULE WITH A 3-WEEK SCHEDULE IN THE TREATMENT OF BREAST CANCERKNIGHT EW; HORTON J; CUNNINGHAM T et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 121-122; BIBL. 7 REF.Article

Effects of model misspecification on tests of no randomized treatment effect arising from Cox's proportional hazards modelDIRIENZO, A. G; LAGAKOS, S. W.Journal of the Royal Statistical Society. Series B, statistical methodology. 2001, Vol 63, Num 4, pp 745-757, issn 1369-7412Article

Estimation of individual and population noncompliance using longitudinal marker data, with application to AIDSHYUNGJIN MYRA KIM; LAGAKOS, S. W.Drug information journal. 1995, Vol 29, pp 1601S-1614S, issn 0092-8615, SUPArticle

Use of tumour lethality to interpret tumorigenicity experiments lacking cause-of-death dataLAGAKOS, S. W; LOUIS, T. A.Applied statistics. 1988, Vol 37, Num 2, pp 169-179, issn 0035-9254Article

Interim analyses using repeated confidence bandsHU, X. J; LAGAKOS, S. W.Biometrika. 1999, Vol 86, Num 3, pp 517-529, issn 0006-3444Article

Size and power of two-sample tests of repeated measures dataDAWSON, J. D; LAGAKOS, S. W.Biometrics. 1993, Vol 49, Num 4, pp 1022-1032, issn 0006-341XArticle

On the representativeness assumption in prevalence tests of carcinogenicityLAGAKOS, S. W; RYAN, L. M.Applied statistics. 1985, Vol 34, Num 1, pp 54-62, issn 0035-9254Article

Nonparametric analysis of truncated survival data, with application to AIDSLAGAKOS, S. W; BARRAJ, L. M; DE GRUTTOLA, V et al.Biometrika. 1988, Vol 75, Num 3, pp 515-523, issn 0006-3444, 9 p.Article

Group sequential analyses for the mean function of a repeated measure processHU, X. J; LAGAKOS, S. W.Statistics in medicine. 1999, Vol 18, Num 17-18, pp 2287-2299, issn 0277-6715Conference Paper

Properties of proportional-hazards score tests under misspecified regression modelsLAGAKOS, S. W; SCHOENFELD, D. A.Biometrics. 1984, Vol 40, Num 4, pp 1037-1048, issn 0006-341XArticle

Should data and safety monitoring boards share confidential interim data?DIXON, D. O; LAGAKOS, S. W.Controlled clinical trials. 2000, Vol 21, Num 1, pp 1-6, issn 0197-2456Article

CD4⁺ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudineSUNGSUB CHOI; LAGAKOS, S. W; SCHOOLEY, R. T et al.Annals of internal medicine. 1993, Vol 118, Num 9, pp 674-680, issn 0003-4819Article